Niadyne Pharma holds an exclusive sublicense agreement with the University of Kentucky and the University of Arizona
for the pharmaceutical application of numerous technologies developed by Elaine and Mike Jacobson. Patent coverage includes composition
of matter for Nia-114 and other nicotinic acid derivatives, methods for delivery of nicotinic acid to skin, and methods and
uses of nicotinic acid for treatment of conditions related to skin barrier impairment. The patent portfolio includes more
than 20 issued US patents and broad foreign coverage.